1) Chimeric oncolytic virus carrying CTLA4 antibody: Previous studies developed a chimeric oncolytic virus incorporating a murine-derived CTLA4 antibody, rFlu-huCTLA4, which has demonstrated tumor growth inhibition in a mouse model of HCC [67]. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.